Two Seas Capital LP Roivant Sciences Ltd. Transaction History
Two Seas Capital LP
- $5.03 Billion
- Q3 2025
A detailed history of Two Seas Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Two Seas Capital LP holds 11,754,164 shares of ROIV stock, worth $238 Million. This represents 3.53% of its overall portfolio holdings.
Number of Shares
11,754,164
Previous 10,598,040
10.91%
Holding current value
$238 Million
Previous $119 Million
48.9%
% of portfolio
3.53%
Previous 2.22%
Shares
16 transactions
Others Institutions Holding ROIV
# of Institutions
374Shares Held
436MCall Options Held
6.03MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...